↓ Skip to main content

PLOS

A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome

Overview of attention for article published in PLOS ONE, March 2012
Altmetric Badge

Mentioned by

policy
2 policy sources
twitter
36 X users
patent
3 patents
facebook
8 Facebook pages
wikipedia
1 Wikipedia page
reddit
1 Redditor

Readers on

mendeley
127 Mendeley
Title
A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome
Published in
PLOS ONE, March 2012
DOI 10.1371/journal.pone.0031334
Pubmed ID
Authors

David R. Strayer, William A. Carter, Bruce C. Stouch, Staci R. Stevens, Lucinda Bateman, Paul J. Cimoch, Charles W. Lapp, Daniel L. Peterson, William M. Mitchell

Abstract

Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a severely debilitating disease of unknown pathogenesis consisting of a variety of symptoms including severe fatigue. The objective of the study was to examine the efficacy and safety of a TLR-3 agonist, rintatolimod (Poly I: C(12)U), in patients with debilitating CFS/ME.

X Demographics

X Demographics

The data shown below were collected from the profiles of 36 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 127 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Spain 1 <1%
Sweden 1 <1%
Italy 1 <1%
Unknown 123 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 22 17%
Student > Master 17 13%
Student > Bachelor 16 13%
Other 12 9%
Student > Doctoral Student 9 7%
Other 21 17%
Unknown 30 24%
Readers by discipline Count As %
Medicine and Dentistry 36 28%
Agricultural and Biological Sciences 18 14%
Immunology and Microbiology 7 6%
Nursing and Health Professions 6 5%
Biochemistry, Genetics and Molecular Biology 6 5%
Other 24 19%
Unknown 30 24%